Amedeo Smart

Free Medical Literature Service




  Free Subscription


1 Am J Hematol
1 Arch Pediatr
1 Blood
1 BMC Cancer
4 Br J Haematol
2 Int J Hematol
1 Kidney Int
1 Leukemia
3 PLoS One

    Am J Hematol

  1. POUCHELON C, Lafont C, Lafarge A, Comont T, et al
    Characteristics and Outcome of Adults With Severe Autoimmune Hemolytic Anemia Admitted to the Intensive Care Unit: Results From A Large French Observational Study.
    Am J Hematol. 2022 Jul 24. doi: 10.1002/ajh.26665.
    >> Share

    Arch Pediatr

  2. MINARY K, Tanne C, Kwon T, Faudeux C, et al
    Outbreak of hemolytic uremic syndrome with unusually severe clinical presentation caused by Shiga toxin-producing Escherichia coli O26:H11 in France.
    Arch Pediatr. 2022;29:448-452.
    >> Share


  3. PINCEZ T, Aladjidi N, Heritier S, Garnier N, et al
    Determinants of long-term outcomes of splenectomy in pediatric autoimmune cytopenias.
    Blood. 2022;140:253-261.
    >> Share

    BMC Cancer

  4. BOENNELYKKE A, Jensen H, Ostgard LSG, Falborg AZ, et al
    Cancer risk in persons with new-onset anaemia: a population-based cohort study in Denmark.
    BMC Cancer. 2022;22:805.
    >> Share

    Br J Haematol

  5. MORICONI C, Dzieciatkowska M, Roy M, D'Alessandro A, et al
    Retention of functional mitochondria in mature red blood cells from patients with sickle cell disease.
    Br J Haematol. 2022;198:574-586.
    >> Share

  6. ROY NBA, Da Costa L, Russo R, Bianchi P, et al
    The use of next-generation sequencing in the diagnosis of rare inherited anaemias: A Joint BSH/EHA Good Practice Paper.
    Br J Haematol. 2022;198:459-477.
    >> Share

  7. NISHIMURA JI, Usuki K, Ramos J, Ichikawa S, et al
    Crovalimab for treatment of patients with paroxysmal nocturnal haemoglobinuria and complement C5 polymorphism: Subanalysis of the phase 1/2 COMPOSER study.
    Br J Haematol. 2022;198:e46-e50.
    >> Share

  8. GAARTMAN AE, Strijdhorst A, van Es N, Tang MW, et al
    Limited value of the D-dimer based YEARS algorithm to rule out pulmonary embolism in sickle cell disease and sickle cell trait.
    Br J Haematol. 2022;198:e42-e45.
    >> Share

    Int J Hematol

  9. CAMASCHELLA C, Pagani A, Silvestri L, Nai A, et al
    The mutual crosstalk between iron and erythropoiesis.
    Int J Hematol. 2022;116:182-191.
    >> Share

  10. MIYAZAKI Y, Kiguchi T, Sato S, Usuki K, et al
    Prospective comparison of 5- and 7-day administration of azacitidine for myelodysplastic syndromes: a JALSG MDS212 trial.
    Int J Hematol. 2022;116:228-238.
    >> Share

    Kidney Int

  11. FUCHS MAA, Kurtz A
    The fate of erythropoietin-producing cells: another piece of the puzzle.
    Kidney Int. 2022;102:230-233.
    >> Share


  12. GROARKE EM, Patel BA, Shalhoub R, Gutierrez-Rodrigues F, et al
    Predictors of clonal evolution and myeloid neoplasia following immunosuppressive therapy in severe aplastic anemia.
    Leukemia. 2022 Jul 27. pii: 10.1038/s41375-022-01636.
    >> Share

    PLoS One

  13. GETA TG, Gebremedhin S, Omigbodun AO
    Prevalence and predictors of anemia among pregnant women in Ethiopia: Systematic review and meta-analysis.
    PLoS One. 2022;17:e0267005.
    >> Share

  14. BATH M, Viveiros A, Schaefer B, Klein S, et al
    Impact of preoperative anemia, iron-deficiency and inflammation on survival after colorectal surgery-A retrospective cohort study.
    PLoS One. 2022;17:e0269309.
    >> Share

  15. AHADZIE-SOGLIE A, Addai-Mensah O, Abaka-Yawson A, Setroame AM, et al
    Prevalence and risk factors of malaria and anaemia and the impact of preventive methods among pregnant women: A case study at the Akatsi South District in Ghana.
    PLoS One. 2022;17:e0271211.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016